| GBP millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 0.1 | 1.2 | 3.8 | 4.6 | 3.7 | 2.0 | −45.0% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 0.1 | 1.2 | 3.8 | 5.9 | 5.6 | 1.1 | −79.6% | |
| Operating income | (0.1) | (1.2) | (3.8) | (5.9) | (5.6) | (1.1) | +79.6% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 2.0 | +53.0% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | (0.0) | (0.0) | (0.0) | 0.0 | (1.6) | (1.7) | −1.9% | |
| Pre-tax income | (0.1) | (1.2) | (3.8) | (5.9) | (7.2) | (2.8) | +61.2% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (0.1) | (1.2) | (3.8) | (5.9) | (7.2) | (2.8) | +61.2% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.00) | (0.02) | (0.04) | (0.05) | (0.10) | (0.02) | +77.2% | |
| EPS, diluted (per share) | (0.00) | (0.02) | (0.04) | (0.05) | (0.10) | (0.02) | +77.2% | |
| EBITDA | 0.0 | (1.2) | (3.8) | (5.9) | (4.5) | (0.8) | +81.8% | |
| Depreciation & amortization | 0.1 | 1.2 | (0.0) | (0.4) | 4.5 | 0.0 | −100.0% | |
| Weighted average shares (shares) | 79,033,242 | 79,033,242 | 105,333,500 | 109,740,000 | 75,200,000 | 126,610,000 | +68.4% | |
| Weighted average diluted shares (shares) | 79,033,242 | 79,033,242 | 105,333,500 | 109,740,000 | 75,200,000 | 126,610,000 | +68.4% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
